RonaldDPerroneMD
Nephrology • Boston, MAHereditary Kidney Disease Genetics
Associate Chief, Nephrology Medical Director Kidney Transplantation
Dr. Perrone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
750 Washington St
# 836
Boston, MA 02111Phone+1 617-636-5000Fax+1 617-636-6204
Education & Training
Boston University Medical CenterFellowship, Nephrology, 1979 - 1981
Emory University School of MedicineResidency, Internal Medicine, 1978 - 1978- Emory University School of MedicineResidency, Internal Medicine, 1975 - 1977
Drexel University College of MedicineClass of 1975
Certifications & Licensure
MA State Medical License 1980 - 2025
NH State Medical License 2024 - 2024
ME State Medical License 2020 - 2021
GA State Medical License 1976 - 1979- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Boston Magazine Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- HALT Progression of Polycystic Kidney Disease Study A Start of enrollment: 2006 Jan 01
- Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2014 May 01
- Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 1024 citationsTolvaptan in patients with autosomal dominant polycystic kidney diseaseVicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Jared J. Grantham
The New England Journal of Medicine. 2012-12-20 - 65 citationsAnalysis of baseline parameters in the HALT polycystic kidney disease trialsVicente E. Torres, Arlene B. Chapman, Ronald D. Perrone, K. Ty Bae, Kaleab Z. Abebe
Kidney International. 2012-03-02 - 91 citationsTotal Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidne...Ronald D. Perrone, Mohamad Samer Mouksassi, Klaus Romero, Frank S. Czerwiec, Arlene B. Chapman
Kidney International Reports. 2017-05-01
Journal Articles
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with TolvaptanRonald D Perrone, Anjay Rastogi, Terry Watnick, Arlene B Chapman, Michal Mrug, Vicente E Torres, Fouad T Chebib, Neera K Dahl, Peter C Harris, Journal of the American Society of Nephrology
- Characterizing Approaches to Dialysis Decision Making with Older AdultsDaniel E Weiner, John B Wong, Ronald D Perrone, Klemens B Meyer, Journal of the American Society of Nephrology
Other
- Assessment of kidney functionPerrone RD, Inker LA
http://www.uptodate.com/contents/assessment-of-kidney-function
UpToDate, Wolters Kluwer Health - 2013-01-08 - Calculation of the creatinine clearancePerrone RD, Inker LA
http://www.uptodate.com/contents/calculation-of-the-creatinine-clearance
UpToDate, Wolters Kluwer Health - 2012-05-23 - Drugs that elevate the serum creatinine concentrationPerrone RD, Inker LA
http://www.uptodate.com/contents/drugs-that-elevate-the-serum-creatinine-concentration
UpToDate, Wolters Kluwer Health - 2012-11-05
Authored Content
- Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis from the HALT-PKD TrialsJanuary 2018
- Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis from the HALT-PKD TrialsJanuary 2018
Press Mentions
'Revolutionary' Drug Offers First Treatment for Devastating Kidney DiseaseMay 29th, 2018
Severe Hyperkalemia Rare Despite Dual RAAS BlockadeDecember 10th, 2015
Grant Support
- Clinical Centers For The Halt-Polycystic Kidney Disease Trials (U01)National Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Polycystic Kidney Disease Clinical Trials NetworkNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2008
- Aldosterone Induced Colonic H+ Secretion &VesiclesNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1988
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
